Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
Specimens of cholesteatoma matrix, meatal epidermis, and middle ear epithelium were removed during surgery, and immunohistochemical techniques were used to investigate cytokeratin expression. The use of five chain-specific anticytokeratin monoclonal antibodies and one broad specific anticytokeratin monoclonal antibody showed the divergent behavior of middle ear epithelium compared with the cytokeratin expression of the other two types of epithelium. Middle ear epithelium was characterized by the presence of cytokeratins 4, 8, 18, and 19, whereas in both cholesteatoma and meatal epidermis cytokeratin 10 predominated. Furthermore, cholesteatoma showed an infrequent focal presence of cytokeratins 4, 18, and 19. The similarity between cholesteatoma and meatal epidermis with respect to morphology, and the presence of cytokeratin 10 support an epidermal origin of cholesteatoma. However, a metaplastic origin cannot be excluded, because of the infrequent occurrence of a small amount of cytokeratins 4, 18, and 19 in cholesteatoma matrix that was not found in meatal epidermis but was a component of the cytokeratin pattern of middle ear epithelium.
Van Blitterswijk
C A
CA
Department of Otorhinolaryngology, Leiden University Hospital, the Netherlands.
Grote
J J
JJ
Lutgert
R W
RW
Hesseling
S C
SC
Out
C J
CJ
Van Muijen
G N
GN
Fransen
J A
JA
D000911:Antibodies, Monoclonal; D002781:Cholesteatoma / Q000378:metabolism* / Q000473:pathology; D004424:Ear Canal; D004427:Ear Diseases / Q000378:metabolism / Q000473:pathology; D004432:Ear, Middle; D004817:Epidermis / Q000378:metabolism / Q000648:ultrastructure; D004848:Epithelium / Q000378:metabolism / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D007633:Keratins